1
|
Brady G, Bennin F, De Koning R, Vindrola-Padros C, Clark SE, Tiwari MK, Watt S, Ducci A, Torii R, Morris D, Lloyd-Dehler E, Slann J, Stevenson F, Khadjesari Z, Dehbi HM, Ciric L, Epstein R, Rubin J, Houlihan CF, Hunter R, Lovat LB. Interventions used to reduce infectious aerosol concentrations in hospitals-a review. EClinicalMedicine 2025; 79:102990. [PMID: 39802303 PMCID: PMC11718292 DOI: 10.1016/j.eclinm.2024.102990] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 05/15/2024] [Revised: 11/13/2024] [Accepted: 11/21/2024] [Indexed: 01/16/2025] Open
Abstract
Background The COVID-19 pandemic highlighted the need for improved infectious aerosol concentrations through interventions that reduce the transmission of airborne infections. The aims of this review were to map the existing literature on interventions used to improve infectious aerosol concentrations in hospitals and understand challenges in their implementation. Methods We reviewed peer-reviewed articles identified on three databases, MEDLINE, Web of Science, and the Cochrane Library from inception to July 2024. 6417 articles were identified, 160 were reviewed and 18 were included. Findings Results on aerosol concentration were discussed in terms of three categories: (1) filtration and inactivation of aerosol particles; (2) effect of airflow and ventilation on aerosol concentrations; and (3) improvements or reduction in health conditions. The most common device or method that was outlined by researchers was high efficiency particulate air (HEPA) filters which were able to reduce aerosol concentrations under investigation across the included literature. Some articles were able to demonstrate the effectiveness of interventions in terms of improving health outcomes for patients. Interpretation The key finding is that infectious aerosol concentration improvement measures based on filtration, inactivation, improved air flow dynamics, and ventilation reduce the likelihood of nosocomial infections. However limitations of such approaches must be considered such as noise pollution and effects on ambient humidity. Whilst these efforts can contribute to improved air quality in hospitals, they should be considered with the other interacting factors such as microclimates, room dimensions and use of chemical products that effect air quality. Funding This study is funded by the National Institute for Health and Care Research (NIHR) (NIHR205439).
Collapse
Affiliation(s)
- Gráinne Brady
- Department of Targeted Intervention, Rapid Research Evaluation and Appraisal Lab (RREAL), University College London, UK
| | - Fiona Bennin
- Department of Targeted Intervention, Rapid Research Evaluation and Appraisal Lab (RREAL), University College London, UK
| | - Rosaline De Koning
- Department of Targeted Intervention, Rapid Research Evaluation and Appraisal Lab (RREAL), University College London, UK
| | - Cecilia Vindrola-Padros
- Department of Targeted Intervention, Rapid Research Evaluation and Appraisal Lab (RREAL), University College London, UK
| | - Sigrún Eyrúnardóttir Clark
- Department of Targeted Intervention, Rapid Research Evaluation and Appraisal Lab (RREAL), University College London, UK
| | - Manish K. Tiwari
- Department of Mechanical Engineering, University College London, UK
- WEISS Centre, University College London, UK
| | - Simon Watt
- Department of Mechanical Engineering, University College London, UK
- WEISS Centre, University College London, UK
| | - Andrea Ducci
- Department of Mechanical Engineering, University College London, UK
| | - Ryo Torii
- Department of Mechanical Engineering, University College London, UK
| | | | | | | | - Fiona Stevenson
- Institute of Epidemiology and Health Care, University College London, UK
| | | | | | - Lena Ciric
- Department of Civil, Environmental and Geomatic Engineering, Healthy Infrastructure Research Group, University College London, UK
| | - Ruth Epstein
- Royal National Throat Nose and Ear Hospital, University College London Hospitals NHS Foundation Trust, London, UK
| | - John Rubin
- Royal National Throat Nose and Ear Hospital, University College London Hospitals NHS Foundation Trust, London, UK
| | - Catherine F. Houlihan
- Department of Virology, University College London Hospitals NHS Foundation Trust, London, UK
- Division of Infection and Immunity, University College London, UK
| | - Rachael Hunter
- Institute of Epidemiology and Health Care, University College London, UK
| | - Laurence B. Lovat
- WEISS Centre, University College London, UK
- Division of Surgery and Interventional Science, University College London, UK
| |
Collapse
|
3
|
Martinot M, Mohseni-Zadeh M, Gravier S, Ion C, Eyriey M, Beigue S, Coutan C, Ongagna JC, Henric A, Schieber A, Jochault L, Kempf C. Nosocomial Coronavirus Disease 2019 during 2020-2021: Role of Architecture and Ventilation. Healthcare (Basel) 2023; 12:46. [PMID: 38200952 PMCID: PMC10779121 DOI: 10.3390/healthcare12010046] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/01/2023] [Revised: 12/16/2023] [Accepted: 12/22/2023] [Indexed: 01/12/2024] Open
Abstract
Nosocomial coronavirus disease 2019 (COVID-19) is a major airborne health threat for inpatients. Architecture and ventilation are key elements to prevent nosocomial COVID-19 (NC), but real-life data are challenging to collect. We aimed to retrospectively assess the impact of the type of ventilation and the ratio of single/double rooms on the risk of NC (acquisition of COVID-19 at least 48 h after admission). This study was conducted in a tertiary hospital composed of two main structures (one historical and one modern), which were the sites of acquisition of NC: historical (H) (natural ventilation, 53% single rooms) or modern (M) hospital (double-flow mechanical ventilation, 91% single rooms). During the study period (1 October 2020 to 31 May 2021), 1020 patients presented with COVID-19, with 150 (14.7%) of them being NC (median delay of acquisition, 12 days). As compared with non-nosocomial cases, the patients with NC were older (79 years vs. 72 years; p < 0.001) and exhibited higher mortality risk (32.7% vs. 14.1%; p < 0.001). Among the 150 NC cases, 99.3% were diagnosed in H, mainly in four medical departments. A total of 73 cases were diagnosed in single rooms versus 77 in double rooms, including 26 secondary cases. Measured air changes per hour were lower in H than in M. We hypothesized that in H, SARS-CoV-2 transmission was favored by short-range transmission within a high ratio of double rooms, but also during clusters, via far-afield transmission through virus-laden aerosols favored by low air changes per hour. A better knowledge of the mechanism of airborne risk in healthcare establishments should lead to the implementation of corrective measures when necessary. People's health is improved using not only personal but also collective protective equipment, i.e., ventilation and architecture, thereby reinforcing the need to change institutional and professional practices.
Collapse
Affiliation(s)
- Martin Martinot
- Infectious Diseases Department, Hôpitaux Civils de Colmar, 68000 Colmar, France; (M.M.-Z.); (S.G.); (C.I.); (S.B.)
| | - Mahsa Mohseni-Zadeh
- Infectious Diseases Department, Hôpitaux Civils de Colmar, 68000 Colmar, France; (M.M.-Z.); (S.G.); (C.I.); (S.B.)
| | - Simon Gravier
- Infectious Diseases Department, Hôpitaux Civils de Colmar, 68000 Colmar, France; (M.M.-Z.); (S.G.); (C.I.); (S.B.)
| | - Ciprian Ion
- Infectious Diseases Department, Hôpitaux Civils de Colmar, 68000 Colmar, France; (M.M.-Z.); (S.G.); (C.I.); (S.B.)
| | - Magali Eyriey
- Clinical Research Department, Hôpitaux Civils de Colmar, 68000 Colmar, France; (M.E.); (J.-C.O.); (A.H.); (A.S.); (C.K.)
| | - Severine Beigue
- Infectious Diseases Department, Hôpitaux Civils de Colmar, 68000 Colmar, France; (M.M.-Z.); (S.G.); (C.I.); (S.B.)
| | - Christophe Coutan
- Technical Department, Hôpitaux Civils de Colmar, 68000 Colmar, France;
| | - Jean-Claude Ongagna
- Clinical Research Department, Hôpitaux Civils de Colmar, 68000 Colmar, France; (M.E.); (J.-C.O.); (A.H.); (A.S.); (C.K.)
| | - Anais Henric
- Clinical Research Department, Hôpitaux Civils de Colmar, 68000 Colmar, France; (M.E.); (J.-C.O.); (A.H.); (A.S.); (C.K.)
| | - Anne Schieber
- Clinical Research Department, Hôpitaux Civils de Colmar, 68000 Colmar, France; (M.E.); (J.-C.O.); (A.H.); (A.S.); (C.K.)
| | - Loic Jochault
- Medical Information Service, Hôpitaux Civils de Colmar, 68000 Colmar, France;
| | - Christian Kempf
- Clinical Research Department, Hôpitaux Civils de Colmar, 68000 Colmar, France; (M.E.); (J.-C.O.); (A.H.); (A.S.); (C.K.)
| |
Collapse
|